Stock info Pfizer | Filter Basic-Info
Stock: Pfizer (US large caps), ISIN: US7170811035
| Last Price | 26.19 | Max Price | 30.72 |
| Min Price | 25.42 | 1 Year return | -48.89 |
| Sector | Health Care | Subsector | Pharmaceuticals |
| Annual report 2020 |
Pfizer
Introduction
It is a famous American pharmaceutical company which has its headquarters in New York City and research headquarters in Groton, Connecticut. It is listed on New York stock exchange. The shares of the company have been a part of the Dow Jones Industrial Average since 2004.Drugs introduced by the company
The company works for the development and production of a vast range of medicines and vaccines including, cardiology, endocrinology, oncology, neurology, and others. The company has on its credit many famous medicines like drug Lipitor (atorvastatin) (used to control LDL blood cholesterol), Lyrica (pregabalin) for neuropathic pain and fibromyalgia, Diflucan (fluconazole), an oral antifungal medication, Zithromax (azithromycin), an antibiotic used to treat throat infections, Viagra (sildenafil) for erectile dysfunction and Celebrex (also Celebra, celecoxib), an anti-inflammatory drug.The reason for the called off merger
In, 2016, a merger was called off between the Pfizer and Allergan, Plc to form an Irish based "Pfizer plc" in a deal that would have been costed $160 billion. The merger was called off in April 2016 due to the of new rules introduced by the United States Treasury against tax inversions, A second largest pharmaceutical settlement has been made by the company with the United States Department of Justice.Contact info:Street: 235 East 42nd StreetZip Code: 10017City: New YorkCountry: USAPhone: 212-733-2323Email: info@pfizer.comWebsite: www.pfizer.comCEO: Ian ReadCFO: Frank D'Amelio
Sector Review Pfizer
| Year | Turnover | Total sector | Market share |
|---|---|---|---|
| 2019 | 51,750 | 615,670 | 8.41 % |
| 2020 | 41,908 | 638,104 | 6.57 % |
| 2021 | 81,288 | 727,997 | 11.17 % |
| 2022 | 100,330 | 787,317 | 12.74 % |
| 2023 | 0 | 0 | 0.00 % |
Advice Pfizer
News Pfizer
Pfizer CEO Bourla says company prepared if modified COVID vaccine required
Pfizer now in top highest dividend yields in America
Pfizer to broaden RSV portfolio with deal to acquire ReViral for up to $525 million
Analysts expect revenue increase Pfizer, quite high dividend
DoD awards Pfizer $1.4B contract modification for 200M COVID vaccine doses for donation
Annual reports Pfizer
| 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
Profile Pfizer
Pfizer
(US7170811035)/ PFEPfizer's headquarter is based in New York. Pfizer mainly operates in the pharmaceutical sector. The CEO of Pfizer is Ian Read. Pfizer' CFO is Frank D'Amelio. The global pharmaceutical companies gained around 75 percent over the last 10 years. As from 2011 the sector is 147 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 75 percent.
The past year was a profitable year for the Pfizer investors
The stock gained over the past 12 months at around 2 percent. Over the past 5 years Pfizer' stock rose at around 51 percent in value. Pfizer's revenues between 2011 and 2015 were quite stable and moved between 58,99 billion dollars and 48,85 billion dollars. Pfizer's net results between 2011 and 2015 were very constant and moved between 8,74 billion dollars and 6,97 billion dollars.
The American company paid out dividends in the past 5 years. Over the past 5 years the stock delivered an average dividend return of 4,8 percent. In the period 2011 till 2015 Pfizer paid it's investors each year a higher dividend per share. So we could call Pfizer a kind of dividend aristocrat.
The American company had ultimo 2015 approximately 78,3 thousand employees on it's payroll.
Pfizer financed with a quite low debt position
As per the end of 2015 the American company's balance sheet equaled 167,46 billion dollars. At the end of 2015 the total debt positon equaled 102,74 billion dollars. This is around 61,35 percent of the total balance sheet. At the end of 2016 the American company was traded with a price/earnings-ratio of around 20. So investors paid 20 times the company's 2015's EPS. We could say that based on it's price/earnings-ratio and dividend yield the American stock can be seen as a value stock.
At the end of 2015 the pharmaceutical company's market capitalization (the number of shares times the market price) equaled around 197,23 billion dollars. At the end of 2015 the American company had around 6,18 billion stocks listed.
All Pfizer's annual reports can be found here. More information about Pfizer can be found it's website. .
Results Pfizer
| Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|---|
| Revenue |
48,851
|
52,824
|
52,546
|
53,647
|
51,750
|
41,908
|
| Costs |
41,892
|
45,610
|
31,239
|
42,495
|
35,478
|
32,749
|
| Profit |
6,959
|
7,214
|
21,307
|
11,152
|
16,272
|
9,159
|
| Margin of profit |
14.25
|
13.66
|
40.55
|
20.79
|
31.44
|
21.86
|
| ROI |
10.75
|
12.12
|
29.88
|
17.59
|
25.77
|
14.48
|
Balance Pfizer
| Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|---|
| Equity |
64,720
|
59,544
|
71,308
|
63,407
|
63,144
|
63,238
|
| Debt |
102,661
|
112,071
|
100,489
|
96,015
|
104,450
|
90,991
|
| Total assets |
167,381
|
171,615
|
171,797
|
159,422
|
167,594
|
154,229
|
| Solvency |
38.67
|
34.70
|
41.51
|
39.77
|
37.68
|
41.00
|
| Cash |
23,290
|
17,850
|
19,992
|
18,833
|
9,646
|
12,221
|
| Cashflow |
14,687
|
16,193
|
16,802
|
15,827
|
12,587
|
14,403
|
| Employees |
0
|
0
|
0
|
0
|
0
|
|
| Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
| Cashflow / Debt |
0.14
|
0.14
|
0.17
|
0.16
|
0.12
|
0.16
|
Details Pfizer
| Details |
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|
| Price |
30.60
|
30.79
|
34.33
|
41.38
|
37.14
|
| Eps |
1.17
|
3.52
|
1.87
|
2.87
|
1.63
|
| Price/earnings-ratio |
26.15
|
8.75
|
18.36
|
14.42
|
16.07
|
| Dividend |
1.20
|
1.28
|
1.36
|
1.44
|
1.52
|
| Dividend % |
3.92 %
|
4.16 %
|
3.96 %
|
3.48 %
|
5.80 %
|
| Payout % |
1.03
|
0.36
|
0.73
|
0.50
|
0.93
|
| Book value |
9.81
|
11.93
|
11.09
|
11.41
|
11.36
|
| Market to book |
0.32
|
0.39
|
0.32
|
0.28
|
0.43
|
| Cashflow per stock |
2.67
|
2.81
|
2.77
|
2.27
|
2.59
|
| Stocks |
6,070
|
5,979
|
5,717
|
5,534
|
5,567
|
| Market Cap |
185.742.00
|
184.093.41
|
196.264.61
|
228.996.92
|
145.799.73
|
Dividend Pfizer
Price info Pfizer
|
Date
|
Price
|
|---|---|
|
13 Nov 2024
|
26.19
|
|
08 Nov 2024
|
27.46
|
|
05 Nov 2024
|
27.76
|
|
31 Oct 2024
|
28.52
|
|
29 Oct 2024
|
28.86
|
|
23 Oct 2024
|
28.84
|
|
19 Oct 2024
|
29.22
|
|
16 Oct 2024
|
29.44
|
|
14 Oct 2024
|
29.16
|
|
05 Oct 2024
|
28.58
|
|
02 Oct 2024
|
28.67
|
|
27 Sep 2024
|
28.97
|
|
20 Sep 2024
|
29.66
|
|
17 Sep 2024
|
30.07
|
|
13 Sep 2024
|
29.16
|
|
28 Aug 2024
|
28.82
|
|
26 Aug 2024
|
28.90
|
|
23 Aug 2024
|
28.78
|
|
11 Aug 2024
|
28.55
|
|
07 Aug 2024
|
28.85
|
|
05 Aug 2024
|
30.43
|
|
01 Aug 2024
|
30.54
|
|
30 Jul 2024
|
30.72
|
|
26 Jul 2024
|
30.18
|
|
23 Jul 2024
|
29.60
|
|
16 Jul 2024
|
29.10
|
|
10 Jul 2024
|
28.35
|
|
09 Jul 2024
|
27.93
|
|
04 Jul 2024
|
27.70
|
|
02 Jul 2024
|
27.99
|
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
